Chemoinformaics analysis of (E)-OCTADEC-9-ENOIC ACID
Molecular Weight | 282.468 | nRot | 15 |
Heavy Atom Molecular Weight | 248.196 | nRig | 2 |
Exact Molecular Weight | 282.256 | nRing | 0 |
Solubility: LogS | -0.342 | nHRing | 0 |
Solubility: LogP | -1.979 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 54.335 |
nHD | 1 | BPOL | 34.977 |
QED | 0.475 |
Synth | 3.501 |
Natural Product Likeliness | -0.044 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.075 |
HIA | 0.015 |
CACO-2 | -6.115 |
MDCK | 0.00344282 |
BBB | 0.4 |
PPB | 0.0857975 |
VDSS | 0.49 |
FU | 0.929886 |
CYP1A2-inh | 0.007 |
CYP1A2-sub | 0.491 |
CYP2c19-inh | 0.019 |
CYP2c19-sub | 0.067 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.45 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.126 |
CYP3a4-inh | 0.01 |
CYP3a4-sub | 0.071 |
CL | 2.141 |
T12 | 0.648 |
hERG | 0.009 |
Ames | 0.028 |
ROA | 0.003 |
SkinSen | 0.171 |
Carcinogencity | 0.023 |
EI | 0.128 |
Respiratory | 0.031 |
NR-Aromatase | 0.002 |
Antiviral | Yes |
Prediction | 0.576912 |